These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8645368)

  • 1. Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study.
    Violi F; Criqui M; Longoni A; Castiglioni C
    Atherosclerosis; 1996 Feb; 120(1-2):25-35. PubMed ID: 8645368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of fibrinogen in an Italian population suffering from claudication. Lower fibrinogen in the south compared to middle and north of Italy. The ADEP Group.
    Basili S; Milani M; Longoni A; Vieri M; Iuliano L; Violi F
    Haematologica; 1998 Aug; 83(8):701-7. PubMed ID: 9793253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).
    Shigematsu H; Nishibe T; Obitsu Y; Matsuzaki K; Ishida A; Miyata T; Shindo S; Hida K; Ohta T; Ando M; Kawasaki T; Yasugi T; Matsumoto T
    Int Angiol; 2010 Apr; 29(2 Suppl):2-13. PubMed ID: 20357743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HAPARG Study. Haemostatic parameters as risk factors in healthy volunteers.
    Breddin HK; Lippold R; Bittner M; Kirchmaier CM; Krzywanek HJ; Michaelis J
    Atherosclerosis; 1999 May; 144(1):211-9. PubMed ID: 10381294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study.
    Achterberg S; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FL; van der Graaf Y; Algra A;
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):424-30. PubMed ID: 20555265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of elevated white blood cell count in hypertension.
    Schillaci G; Pirro M; Pucci G; Ronti T; Vaudo G; Mannarino MR; Porcellati C; Mannarino E
    Am J Hypertens; 2007 Apr; 20(4):364-9. PubMed ID: 17386341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
    Neri Serneri GG; Coccheri S; Marubini E; Violi F;
    Eur Heart J; 2004 Oct; 25(20):1845-52. PubMed ID: 15474700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes.
    Mehler PS; Coll JR; Estacio R; Esler A; Schrier RW; Hiatt WR
    Circulation; 2003 Feb; 107(5):753-6. PubMed ID: 12578880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
    Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
    Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
    Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Asymptomatic arteriopathy of the lower limbs. Prevalence and risk factors in a population of southern Italy].
    Pujia A; Gnasso A; Mancuso G; Spagnuolo M; Cosco C; Cortese C; Colonna A; Mattioli PL
    Minerva Cardioangiol; 1993 Apr; 41(4):133-8. PubMed ID: 8332269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The progressive nature of peripheral arterial disease in young adults: a prospective analysis of white men referred to a vascular surgery service.
    Valentine RJ; Jackson MR; Modrall JG; McIntyre KE; Clagett GP
    J Vasc Surg; 1999 Sep; 30(3):436-44. PubMed ID: 10477636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and prognostic influence of peripheral arterial disease in patients >or=40 years old admitted into hospital following an acute coronary event.
    Bertomeu V; Morillas P; Gonzalez-Juanatey JR; Quiles J; Guindo J; Soria F; Llacer A; Lekuona I; Mazón P; Martín-Luengo C; Rodriguez-Padial L;
    Eur J Vasc Endovasc Surg; 2008 Aug; 36(2):189-196. PubMed ID: 18375154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study.
    Barzilay JI; Peterson D; Cushman M; Heckbert SR; Cao JJ; Blaum C; Tracy RP; Klein R; Herrington DM
    Am J Kidney Dis; 2004 Jul; 44(1):25-34. PubMed ID: 15211434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology and risk factors for cardiovascular diseases in women].
    Giampaoli S; Menotti A
    Ann Ist Super Sanita; 1992; 28(3):335-41. PubMed ID: 1492730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of picotamide in the reduction of cardiovascular events in diabetic patients.
    Celestini A; Violi F
    Vasc Health Risk Manag; 2007; 3(1):93-8. PubMed ID: 17583179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery.
    Huang AL; Silver AE; Shvenke E; Schopfer DW; Jahangir E; Titas MA; Shpilman A; Menzoian JO; Watkins MT; Raffetto JD; Gibbons G; Woodson J; Shaw PM; Dhadly M; Eberhardt RT; Keaney JF; Gokce N; Vita JA
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2113-9. PubMed ID: 17717291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for the occurrence of epistaxis: Prospective study.
    Côrte FC; Orfao T; Dias CC; Moura CP; Santos M
    Auris Nasus Larynx; 2018 Jun; 45(3):471-475. PubMed ID: 28844608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: data from the prospective Second Manifestations of ARTerial disease (SMART) cohort study.
    Sprengers RW; Janssen KJ; Moll FL; Verhaar MC; van der Graaf Y;
    J Vasc Surg; 2009 Dec; 50(6):1369-76. PubMed ID: 19837547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.